Zydus Cadila receives USFDA nod to market fluconazole tablet
Drug firm Zydus Cadila has received approval from the US health regulator to market fluconazole tablets used for the treatment of fungal infections. The company also received approval for Clobetasol Propionate spray used in the treatment of various skin disorders.
Fluconazole Tablets will be marketed in strengths of 50 mg, 100 mg, 150 mg and 200 mg and Clobetasol Propionate spray, 0.05 per cent.
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-receives-usfda-nod-to-market-fluconazole-tablets/articleshow/57203689.cms
S●●●●●p D●●●i and 1 others like this
Like
Comment
Share
S●●●●●●a ch
s●●●●●●a ch Ayurvedic Medicine
Hi
Feb 18, 2017Like